Today in Medicine
SEE OTHER BRANDS

Fresh medicine news from the world

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.

Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025

Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025

NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2025 financial results on Wednesday, August 6, 2025 before the U.S. financial markets open. The company will host...

Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal

Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal

Revised Potential Distribution Range of $0.03 to $0.07 per share based on current estimates and assumptions Failure to approve Dissolution Proposal on a timely basis will result in continued operating costs and further reduce or eliminate any...

Governor Katie Hobbs Erases $429 Million in Medical Debt for Hundreds of Thousands of Arizonans

Governor Katie Hobbs Erases $429 Million in Medical Debt for Hundreds of Thousands of Arizonans

Medical debt has profoundly harmful consequences for individuals and the communities they live in, leading to postponement of critical and often lifesaving care, declining credit scores and job opportunities, and physical and mental health issues....

Snapscale Launches its SafeBase Initiative (SBI) the Outsourcing Industry’s First HIPAA Compliance Program Designed for Virtual Medical Assistants

Snapscale Launches its SafeBase Initiative (SBI) the Outsourcing Industry’s First HIPAA Compliance Program Designed for Virtual Medical Assistants

Scotch Plains, NJ, July 16, 2025 (GLOBE NEWSWIRE) -- Snapscale (formerly BBC Global Services) a leading provider of HIPAA-compliant outsourcing solutions today announced the premier of the outsourcing industry’s first-ever SafeBase Initiative...

Attorney General Tong Files Proof of Claim in Prospect Medical Holdings Bankruptcy

Attorney General Tong Files Proof of Claim in Prospect Medical Holdings Bankruptcy

Press Releases 07/16/2025 Attorney General Tong Files Proof of Claim in Prospect Medical Holdings Bankruptcy (Hartford, CT) – Attorney General William Tong announced today the Office of the Attorney General has filed a proof of claim in the...

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price...

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

SARASOTA, FL, July 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of...

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, 2025 (GLOBE NEWSWIRE) --...

Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement

Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement

GLEN ALLEN, Va., July 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and...

Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra™ (Resmetirom)

Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra™ (Resmetirom)

• Provides Protection Through Sept. 2044; Will Be Listed in FDA’s Orange Book CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics...

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment....

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

-- Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- -- Prime Medicine to receive up to $24 million in additional funding from the Cystic Fibrosis Foundation -- -- Multiple...

IBN Initiates Coverage of Lantern Pharma Inc.

IBN Initiates Coverage of Lantern Pharma Inc.

AUSTIN, Texas, July 16, 2025 (GLOBE NEWSWIRE) -- via IBN -- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted cancer therapies using its proprietary RADR® AI platform to transform the cost, pace and...

Covalent Medical - 695839 - 07/09/2025

Covalent Medical - 695839 - 07/09/2025

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Clint Worley, COO Covalent Medical 24600 Millstream Drive, Ste 410 Aldie, VA 20105 United States CWORLEY@focusvitamins.com Issuing Office: Center for Drug Evaluation and Research...

Nashville Concierge Medicines Launches New Website for Patients Seeking Private or Concierge Doctors in Nashville

Nashville Concierge Medicines Launches New Website for Patients Seeking Private or Concierge Doctors in Nashville

A newly launched website offers a clear, modern view into the clinic’s personalized approach to healthcare for men and women in Nashville, Tennessee. NASHVILLE, TN, UNITED STATES, July 16, 2025 /⁨EINPresswire.com⁩/ -- Nashville Concierge...

UROGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Class Action Lawsuit Against UroGen Pharma Ltd. And Encourages Investors to Contact the Firm

UROGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Class Action Lawsuit Against UroGen Pharma Ltd. And Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In UroGen Pharma (URGN) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in UroGen between July 27, 2023...

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30,...

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to...

 Hydration Is Safety: Protecting Youth Athletes from Dehydration & Heat Illness

Hydration Is Safety: Protecting Youth Athletes from Dehydration & Heat Illness

Even at the collegiate level - where medical support is more comprehensive - the risks remain high - NAPLES, FL, UNITED STATES, July 20, 2025 /⁨EINPresswire.com⁩/ -- Naples Soccer Academy (NSA), a club-neutral 501(c)(3) nonprofit dedicated...

Arizona Imaging Group Southwest Medical Imaging Achieves 89% Script Upload Success with ScriptAid by Cranberry Peak

Arizona Imaging Group Southwest Medical Imaging Achieves 89% Script Upload Success with ScriptAid by Cranberry Peak

Southwest Medical Imaging used Cranberry Peak’s ScriptAid SaaS to streamline script collection. 275+ staff onboarded in 2 weeks, 85% uploaded <5 min. CAMBRIDGE, MA, UNITED STATES, July 15, 2025 /⁨EINPresswire.com⁩/ -- Southwest Medical Imaging...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service